Alterity Therapeutics (ATHE) Profit After Tax (2016 - 2024)
Alterity Therapeutics' quarterly Profit After Tax came in at -$12.8 million in Q2 2024, down 36.64% year-on-year from -$20.1 million in Q3 2023, and down 36.64% quarter-over-quarter from -$9.3 million in Q2 2023.
Alterity Therapeutics has reported Profit After Tax for 8 years, with the latest figure at -$12.8 million in Q2 2024.
- For the quarter ending Q2 2024, Profit After Tax fell 36.64% year-over-year to -$12.8 million; the trailing twelve-month figure through Jun 2024 stood at -$12.8 million (down 36.64% YoY), and the FY2025 full-year result was -$7.8 million, up 38.27% from the prior year.
- Profit After Tax for Q2 2024 stood at -$12.8 million, down from -$9.3 million in the prior quarter.
- The five-year high for Profit After Tax was -$6.6 million in Q2 2020, with the low at -$12.8 million in Q2 2024.
- Average Profit After Tax over 4 years is -$9.5 million, with a median of -$9.3 million recorded in 2022.
- Year-over-year, Profit After Tax advanced 23.71% in 2020 and tumbled 36.64% in 2024.
- Tracing ATHE's Profit After Tax over 4 years: stood at -$6.6 million in 2020, then slumped by 41.44% to -$9.3 million in 2022, then dropped by 0.1% to -$9.3 million in 2023, then plunged by 36.64% to -$12.8 million in 2024.
- The last three Profit After Tax figures came in at -$12.8 million (Q2 2024), -$9.3 million (Q2 2023), and -$9.3 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -12.76 Mn |
| Jun 30, 2023 | -9.34 Mn |
| Jun 30, 2022 | -9.33 Mn |
| Jun 30, 2020 | -6.59 Mn |
| Dec 31, 2019 | -3.85 Mn |
| Jun 30, 2019 | -8.64 Mn |
| Dec 31, 2018 | 3.83 Mn |
| Jun 30, 2018 | -62,574.68 |
| Dec 31, 2017 | -2.78 Mn |
| Jun 30, 2017 | -5.67 Mn |
| Dec 31, 2016 | -2.74 Mn |
| Jun 30, 2016 | -5.77 Mn |